Regeneron Pharmaceuticals, Inc. - Company Profile and SWOT Analysis

May 2026 | 58 pages | ID: RA4783DF6ECEN
MarketLine

Abstracts

Summary

Regeneron Pharmaceuticals, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Regeneron Pharmaceuticals, Inc. (Regeneron) is a biotechnology company engaged in the invention, development, manufacturing, and commercialization of medicines aimed at treating serious diseases. The company focuses on various therapeutic areas, including eye diseases, cardiovascular and metabolic disorders, allergic and inflammatory conditions, cancer, neurological diseases, hematologic issues, infectious diseases, and rare diseases. Regeneron utilizes its Trap and VelociSuite technology platforms for product development. It offers medicines through brands such as EYLEA, Dupixent, Libtayo, Praluent, Evkeeza, and Inmazeb, distributed to pharmacies, hospitals, government agencies, physicians, and other healthcare providers in multiple countries, including the US, the Netherlands, Ireland, Spain, India, Japan, and the UK. The company has manufacturing facilities located in the US and Ireland. Regeneron is headquartered in Tarrytown, New York.

Scope

• Detailed information on Regeneron Pharmaceuticals, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Regeneron Pharmaceuticals, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Regeneron Pharmaceuticals, Inc. including a breakdown and examination of key business segments
• Intelligence on Regeneron Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Regeneron Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Regeneron Pharmaceuticals, Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Regeneron Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Regeneron Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
Regeneron Pharmaceuticals, Inc.: Company Overview
Regeneron Pharmaceuticals, Inc.: Overview and Key Facts
Regeneron Pharmaceuticals, Inc.: Overview
Regeneron Pharmaceuticals, Inc.: Key Facts
Regeneron Pharmaceuticals, Inc.: Key Employees
Regeneron Pharmaceuticals, Inc.: Key Employee Biographies
Regeneron Pharmaceuticals, Inc.: Major Products and Services
Regeneron Pharmaceuticals, Inc.: Management Statement
Regeneron Pharmaceuticals, Inc.: Locations and Subsidiaries
Regeneron Pharmaceuticals, Inc.: Key Competitors
Regeneron Pharmaceuticals, Inc.: Company Analysis
Regeneron Pharmaceuticals, Inc.: Business Description
Regeneron Pharmaceuticals, Inc.: SWOT Analysis
Regeneron Pharmaceuticals, Inc.: SWOT Overview
Regeneron Pharmaceuticals, Inc.: Strengths
Regeneron Pharmaceuticals, Inc.: Weaknesses
Regeneron Pharmaceuticals, Inc.: Opportunities
Regeneron Pharmaceuticals, Inc.: Threats
Regeneron Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Regeneron Pharmaceuticals, Inc.: Financial Deals Overview
Regeneron Pharmaceuticals, Inc.: Targets and Partners
Regeneron Pharmaceuticals, Inc.: Top Deals 2022 - 2026YTD*
Regeneron Pharmaceuticals, Inc.: Advisors
Regeneron Pharmaceuticals, Inc.: Top Legal Advisors
Regeneron Pharmaceuticals, Inc.: Top Financial Advisors
Regeneron Pharmaceuticals, Inc.: Mergers and Acquisitions
Regeneron Pharmaceuticals, Inc.: Corporate Venturing
Regeneron Pharmaceuticals, Inc.: Partnership
Regeneron Pharmaceuticals, Inc.: Private Equity and Ownership
Regeneron Pharmaceuticals, Inc.: Recent Developments
Regeneron Pharmaceuticals, Inc.: News and Events Summary
Regeneron Pharmaceuticals, Inc.: Corporate Governance
Regeneron Pharmaceuticals, Inc.: Financial Performance
Regeneron Pharmaceuticals, Inc.: Market Developments
Regeneron Pharmaceuticals, Inc.: Regulatory and Legal Events
Regeneron Pharmaceuticals, Inc.: Research & Development
Regeneron Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Regeneron Pharmaceuticals, Inc.: Key Facts
Table 2: Regeneron Pharmaceuticals, Inc.: Key Employees
Table 3: Regeneron Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 4: Regeneron Pharmaceuticals, Inc.: Key Competitors
Table 5: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Regeneron Pharmaceuticals, Inc.: M&A Activity by Geography (TTM*)
Table 7: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Table 8: Regeneron Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Regeneron Pharmaceuticals, Inc.: Targets and Partners
Table 10: Regeneron Pharmaceuticals, Inc.: Top Deals 2022 - 2026YTD*
Table 11: Regeneron Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Regeneron Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Regeneron Pharmaceuticals, Inc.: M&A Volume and Value Trend (2022 - YTD*2026)
Table 14: Regeneron Pharmaceuticals, Inc.: M&A Activity by Geography (2022 - YTD*2026)
Table 15: Regeneron Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2022 - YTD*2026)
Table 16: Regeneron Pharmaceuticals, Inc.: Corporate Venturing by Geography (2022 - YTD*2026)
Table 17: Regeneron Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026)
Table 18: Regeneron Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026)
Table 19: Regeneron Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2022 - YTD*2026)
Table 20: Regeneron Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2022 - YTD*2026)
Table 21: Regeneron Pharmaceuticals, Inc.: News and Events Summary
Table 22: Regeneron Pharmaceuticals, Inc.: Corporate Governance
Table 23: Regeneron Pharmaceuticals, Inc.: Financial Performance
Table 24: Regeneron Pharmaceuticals, Inc.: Market Developments
Table 25: Regeneron Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 26: Regeneron Pharmaceuticals, Inc.: Research & Development
Table 27: Regeneron Pharmaceuticals, Inc.: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Regeneron Pharmaceuticals, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Figure 4: Regeneron Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Regeneron Pharmaceuticals, Inc.: M&A Volume and Value Trend (2022 - YTD*2026)
Figure 6: Regeneron Pharmaceuticals, Inc.: M&A Activity by Geography (2022 - YTD*2026)
Figure 7: Regeneron Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2022 - YTD*2026)
Figure 8: Regeneron Pharmaceuticals, Inc.: Corporate Venturing by Geography (2022 - YTD*2026)
Figure 9: Regeneron Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026)
Figure 10: Regeneron Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026)
Figure 11: Regeneron Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2022 - YTD*2026)
Figure 12: Regeneron Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2022 - YTD*2026)